Skip to main content

Zimmer Biomet statistics

  • ZBH · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$103.21−1.29%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$26.65B
EV / EBITDA11.75
EV / sales3.11

Share price

Latest close$103.21
Day's change−1.3%
52-week high$112.55
52-week low$79.12
From 52-week high−8.3%
Return · 1 month+8.7%
Return · 3 months+4.3%
Return · year to date+14.8%
Return · 1 year+14.6%
Beta · 1 year against the S&P 5000.40
50-day average$95.77
200-day average$92.53
RSI 1455.9
Average volume · 20 sessions2.4M

Margins and returns

For fiscal 2025, as filed.

Gross margin69.7%
Operating margin13.3%
Net margin8.6%
Free cash flow margin17.9%
Return on equity5.6%
Return on assets4.2%
Return on invested capital4.7%
Return on capital employed5.6%
Stock-based compensation / revenue1.1%

Financial position

At the end of fiscal 2025.

Cash and equivalents$591.9M
Total debt$7.75B
Net debt$7.16B
Current ratio1.98
Debt / equity0.61
Net debt / EBITDA3.27

Shares and dividends

For fiscal 2025, as filed.

Diluted shares199M
Net share repurchases$447.3M
Dividends per share$0.96
Dividend payout27.0%

Taxes

For fiscal 2025, as filed.

Income tax expense$125.7M
Effective tax rate15.1%

ZBH in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.